{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:43Z","timestamp":1786649923314,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Plasmablastic lymphoma (PBL) is an aggressive lymphoma and is regarded as a subtype of diffuse large B-cell lymphoma (DLBCL). It is generally found in immunosuppressed and transplanted individuals, but very less often in immunocompetent individuals. It shows positivity for Epstein\u2013Barr virus (EBV) infection in 60% of cases. Few cases have been seen in immunocompetent patients, but rarely as cutaneous manifestations. In the recent past, very few studies have discussed the cytological features of PBL. Due to its rarity, diagnosis and management of this unique entity pose a challenge. Moreover, it is also important to differentiate this entity from other close mimics, especially PBL, which morphologically resembles PBL. We hereby present a rare case of aggressive PBL, presenting with multiple cutaneous manifestations, initially diagnosed on aspiration cytology.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_922_22","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T16:12:45Z","timestamp":1743696765000},"page":"247-250","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Plasmablastic lymphoma with cutaneous manifestations in an immunocompetent man: A rare case report with literature review"],"prefix":"10.4103","volume":"21","author":[{"given":"Dimple","family":"Chaudhary","sequence":"first","affiliation":[{"name":"Department of Pathology and Surgery, Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shramana","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Surgery, Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Pathology and Surgery, Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Pathology and Surgery, Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawanindra","family":"Lal","sequence":"additional","affiliation":[{"name":"Department of Pathology and Surgery, Maulana Azad Medical College and Associated Hospitals, New Delhi, Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"R1-20250403","first-page":"44","article-title":"Interactions between life expectancy and the incidence and mortality rates of cancer in China: A population-based cluster analysis","volume":"38","author":"Gu","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"R2-20250403","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"R3-20250403","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clml.2011.03.008","article-title":"HIV-negative plasmablastic lymphoma: Not in the mouth","volume":"11","author":"Castillo","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R5-20250403","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.jaad.2013.06.050","article-title":"Primary cutaneous plasmablastic lymphoma in an immunocompetent patient","volume":"69","author":"Horna","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R6-20250403","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/541783","article-title":"Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocythemia: A case report and literature review","author":"Tiong","year":"2013","journal-title":"Case Rep Hematol 2013"},{"key":"R7-20250403","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jaad.2012.02.021","article-title":"Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient","volume":"67","author":"Heiser","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R8-20250403","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1100\/tsw.2011.59","article-title":"Plasmablastic lymphoma: A systematic review","volume":"11","author":"Castillo","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"R9-20250403","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: Report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Li","year":"2020","journal-title":"Blood Res"},{"key":"R10-20250403","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"R11-20250403","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3892\/or.2015.3808","article-title":"Human immunodeficiency virus-negative plasmablastic lymphoma: A comprehensive analysis of 114 cases","volume":"33","author":"Liu","year":"2015","journal-title":"Oncol Rep"},{"key":"R12-20250403","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.clml.2013.12.003","article-title":"BRAF V600E mutation and clonal evolution in a patient with relapsed refractory myeloma with plasmablastic differentiation","volume":"14","author":"Bohn","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R13-20250403","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5732\/cjc.011.10420","article-title":"R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma","volume":"31","author":"He","year":"2012","journal-title":"Chin J Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_922_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:59:55Z","timestamp":1786647595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_922_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_922_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2022-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}